DrugPatentWatch Database Preview
ADHANSIA XR Drug Profile
Email this page to a colleague
Which patents cover Adhansia Xr, and what generic alternatives are available?
Adhansia Xr is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are twelve patents protecting this drug.
This drug has twenty-seven patent family members in seventeen countries.
The generic ingredient in ADHANSIA XR is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adhansia Xr
A generic version of ADHANSIA XR was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
Summary for ADHANSIA XR
| International Patents: | 27 |
| US Patents: | 12 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ADHANSIA XR |
| What excipients (inactive ingredients) are in ADHANSIA XR? | ADHANSIA XR excipients list |
| DailyMed Link: | ADHANSIA XR at DailyMed |
Recent Clinical Trials for ADHANSIA XR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Purdue Pharma LP | Phase 4 |
ATC Classes for ADHANSIA XR
US Patents and Regulatory Information for ADHANSIA XR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-006 | Feb 27, 2019 | RX | Yes | Yes | Get Started Free | Get Started Free | Y | Get Started Free | |||
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-004 | Feb 27, 2019 | RX | Yes | No | Get Started Free | Get Started Free | Get Started Free | ||||
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-003 | Feb 27, 2019 | RX | Yes | No | Get Started Free | Get Started Free | Y | Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ADHANSIA XR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Chile | 2017001026 | Get Started Free |
| Japan | 2017532363 | Get Started Free |
| Canada | 2936741 | Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
